ArticleTherapeutics and clinical risk management2010

Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.

Ayman A Hussein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.